Strategies for malaria vaccination during the Covid-19 pandemic in African countries

dc.contributor.authorNarain, Kapil
dc.contributor.authorRackimuthu, Sudhan
dc.contributor.authorOkonji, Osaretin Christabel
dc.date.accessioned2023-03-22T13:24:05Z
dc.date.available2023-03-22T13:24:05Z
dc.date.issued2022
dc.description.abstractSince October 2021, the World Health Organization (WHO) recommends the use of RTS,S/AS01 (RTS,S) malaria vaccine for children in areas of moderate to high transmission of Plasmodium falciparum in Africa.1 The vaccine can reduce the 241 million cases of malaria and 627 000 malaria deaths worldwide;2,3 it is much needed in the WHO African Region, which accounts for 228 million cases of malaria (95% of global cases) and about 96% of global malaria deaths.2 However, an effective vaccine roll-out in Africa can only be achieved when region-specific challenges can be overcome; intraregional inequality, health-care systems strengthening and lessons from community engagement in previous public health crises.en_US
dc.identifier.citationNarain, K. et al. (2022). Strategies for malaria vaccination during the Covid-19 pandemic in African countries. Bulletin of the World Health Organization, ;100, 582–582A. http://dx.doi.org/10.2471/BLT.21.287472en_US
dc.identifier.issn1564-0604
dc.identifier.urihttp://dx.doi.org/10.2471/BLT.21.287472
dc.identifier.urihttp://hdl.handle.net/10566/8647
dc.language.isoenen_US
dc.publisherWorld Health Organizationen_US
dc.subjectCovid-19en_US
dc.subjectPublic healthen_US
dc.subjectWorld Health Organization (WHO)en_US
dc.subjectMalariaen_US
dc.subjectAfricaen_US
dc.titleStrategies for malaria vaccination during the Covid-19 pandemic in African countriesen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
narain_strategies for malaria vaccination_2022.pdf
Size:
1.96 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: